Pharma still doesn’t quite ‘get’ customer experience and remains significantly out of sync with consumer sentiment. This post lays out why pharma needs to think customer first.

As physicians increasingly turn to digital for information gathering disease, treatment and brand websites are inevitably necessary and…

Biogen Idec has partnered with Google X, Google’s business unit for long-term “moonshot” projects, to study outside factors that might contribute to the progression of multiple sclerosis (MS), according to a report from Bloomberg.

Google and Biogen will use sensors, software, and data analysis tools to collect and analyze data from people who have MS. The companies aim to explore why MS progresses differently in each patient.

Bloomberg pointed out that Biogen has used digital tools for its disease research in the past. Last month, Biogen announced that it was using Fitbit activity trackers to gather data from people who have MS. It gave 250 Fitbit bands to participants to track their level of activity and sleep patterns. Last summer, the pharma company worked with Cleveland Clinic to develop an iPad app to assess MS progression. 

more at http://mobihealthnews.com/40031/google-biogen-will-use-wearable-sensors-to-study-multiple-sclerosis/

Validé par des experts rhumatologues, le site Arthrocoach.com fourmille de conseils pratiques. Ce service en ligne totalement gratuit a été conçu pour acco

While biotech/pharma is set to reach a high in investment dollars this year, the exits and growth of digital health are trumping traditional life science deals.